Epigenomics AG to Present at the 3rd Annual Rodman & Renshaw Global Healthcare Conference in Monte Carlo
11 mai 2006 11h10 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, May 11, 2006 (PRIMEZONE) -- The German biotech company Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) announced today that the company will be presenting at the 3rd...
Epigenomics AG Reports First Quarter 2006 Results
03 mai 2006 02h23 HE
|
Epigenomics AG
BERLIN and SEATTLE, May 3, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial...
Clinical Study Proves Prognostic Power of Epigenomics' Biomarker in Prostate Cancer
05 avr. 2006 11h10 HE
|
Epigenomics AG
BERLIN and SEATTLE, April 5, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today presented data...
Epigenomics Presents Data Confirming Screening for Methylated DNA in Blood as Key to Early Colorectal Cancer Detection
03 avr. 2006 13h35 HE
|
Epigenomics AG
BERLIN, April 3, 2006 (PRIMEZONE) -- Epigenomics AG Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today confirmed that...
Epigenomics AG Reports Financial Results for Fiscal Year 2005
24 mars 2006 02h09 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, March 24, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today...
Ad hoc: Epigenomics AG Reports Extension of Blood Screening Product Collaboration
22 mars 2006 15h34 HE
|
Epigenomics AG
BERLIN and SEATTLE, March 22, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, announced today an...
Epigenomics AG to Host Press Conference and Analyst Meeting for 2005 Annual Results
17 mars 2006 09h39 HE
|
Epigenomics AG
BERLIN and SEATTLE, March 17, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF) will hold a press conference and analyst meeting on March 24, 2006 to present results for the fiscal...
Epigenomics AG Pursuing Development of Tamoxifen Response Test
30 janv. 2006 02h41 HE
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Roche...
Epigenomics AG adds Regulatory Affairs and Marketing Expertise to Senior Management
04 janv. 2006 03h08 HE
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...
Epigenomics Successfully Completes Biomarker Validation Study for Prostate Cancer Classification Test
04 janv. 2006 02h11 HE
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...